San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Funds Help Biotech Track ‘Moving Target’

Life Science: Epic’s Cancer Diagnostics Generate Interest

A rapidly growing diagnostics company in San Diego has raised $30 million in Series C financing to help commercialize its new technology for cancer research, while adding a high-profile life science veteran to its board.

Sorrento Therapeutics' Chief Business Officer Amar Singh Passed Away

Sorrento Therapeutics Inc. announced the death of its Chief Business Officer and Executive Vice President Amar Singh.

Human Longevity Inc. Hires Former Google Exec as Chief Data Scientist

A diagnostic and therapeutic company in La Jolla has recruited Franz Och, scientist and former head of Google Translate, as the company’s chief data scientist.

Tease photo

Illumina Appoints Google Exec Huber to Its Board

Illumina Inc. announced that Jeff Huber, senior vice president at Google Inc., has been appointed to its board of directors.

Tease photo

Epic Sciences Raises $30M, Names Lucier New Director and Board Chairman

A diagnostics company in San Diego has raised $30 million in Series C financing to help commercialize its new technology for cancer research.

Tease photo

CareFusion Subsidiary Receives Warning From FDA

The Food and Drug Administration has warned CareFusion 2200 Inc., a subsidiary of San Diego-based CareFusion Corp., that it failed to satisfactorily investigate and respond to 32 complaints of particulate matter and debris found in certain medical devices

Sequenom Reports Q2 Results, Inks License Agreement With Mayo Medical

Sequenom Inc., a life sciences company that provides genetic analysis solutions, and Mayo Medical Laboratories, one of the top providers of esoteric laboratory services in the U.S., have announced a license agreement for Sequenom’s noninvasive prenatal testing patents and applications.

NuVasive Reports Q2 Revenue of $190.7 Million

NuVasive reported second quarter 2014 revenue of $190.7 million as compared with $165.7 million from the previous year.

Tease photo

La Jolla Pharmaceutical Co. Closes Common Stock Offering

La Jolla Pharmaceutical Co., a therapeutics company focused on unmet life-threatening diseases, announced the closing of its underwritten $56.6 million public offering.

PaxVax Secures $62 Million in Funding

PaxVax, Inc., a Redwood City-based vaccine company with manufacturing facilities in San Diego, announced that it has secured up to $62 million in additional funding as part of the acquisition of an oral typhoid vaccine, Vivotif, from Crucell Switzerland AG.

Quidel Receives FDA Clearance for Strep Diagnostic

Quidel Corp., a San Diego-based diagnostics company, has received FDA clearance for its molecular diagnostic test, AmpliVue GAS Assay, used for detecting Group A strep.

Cypher Genomics Inc. Teams With Illumina, Also Names President and COO

San Diego-based Cypher Genomics Inc. announced a co-promotion agreement with Illumina Inc. and the selection of Adam Simpson as president and chief operating officer.

Tease photo

DJO Global Reports Q2 Results

DJO Global Inc., the Vista-based maker of orthopedic devices, reporter second quarter net sales of $313.9 million, up 6.5 percent from the like quarter of 2013.

Pfenex Raises $50 Million in IPO

Pfenex Inc., a Sorrento Valley biotech firm specializing in a class of drugs called biosimilars, raised $50 million in its initial public offering July 23, selling 8.33 million shares at $6 per share.

La Jolla Pharmaceutical Prices Stock Offering

La Jolla Pharmaceutical Co., a developer of therapeutics targeting unmet life-threatening diseases, announced a price of $10.50 per share for a planned underwritten stock offering of 4.8 million shares of common stock.